OcuLight® SL Laser The OcuLight® SL 810 nm infrared laser console offers high performance for retinal photocoagulation and glaucoma procedures, including transscleral applications. ° Solid-state, semiconductor technology requires no regular maintenance ° Compact design allows for easy transport to the office, clinic and operating room ° Multiple delivery devices optimize clinical versatility Indications for Use Indication Delivery Device Glaucoma – Primary Open Angle – Closed Angle – Refractory Glaucoma Laser Trabeculoplasty; Iridotomy; Transscleral Cyclophotocoagulation Slit Lamp Adapters (SLA); G-Probe™ Diabetic Retinopathy – Nonproliferative Retinopathy – Macular Edema – Proliferative Retinopathy Panretinal Photocoagulation (PRP); Focal and Grid Laser Treatments SLA; EndoProbe®; Laser Indirect Ophthalmoscope (LIO) Retinal Tears, Detachments, and Holes Transscleral Retinal Photocoagulation (TSRPC); Focal and Grid Laser Treatments Lattice Degeneration PRP; Focal and Grid Laser Treatments Age-Related Macular Degeneration (AMD) Focal and Grid Laser Treatments PRP; TSRPC; Focal and Grid Laser Treatments Sub-Retinal (choroidal) Neovascularization Focal and Grid Laser Treatments Central and Branch Retinal Vein Occlusion PRP; Focal and Grid Laser Treatments

OcuLight® SL Laser Specifications Wavelength: Connector Type: Exposure Duration: Exposure Interval: Aiming Laser: Diode laser, 655 nm nominal Delivery Device Power Output: Portable SLA: 0–1300 mW LIO: 0–1500 mW LIO-LS*: 0–1500 mW EndoProbe®: 0–1500 mW G-Probe™: 0–2000 mW DioPexy™: 0–1800 mW OMA: 0–1300 mW *Factory installed option Specifications are subject to change without notice. OcuLight, EndoProbe, IRIDEX and the IRIDEX logo are registered trademarks and G-Probe, CW-Pulse and DioPexy are trademarks of IRIDEX Corporation. Products are covered by one or more of the following U.S. patents:...